Extract from the page which also contains an email from Dr
Ilyria Capua herself dated 9 March 2006 about her proposal
ProMED-mail welcomes the opportunity to support Dr.
Capua's proposal.
The background to this proposal is provided in an
article by Martin
Enserink, which appeared in "Science" on 3 Mar
2006
(Vol. 311. no. 5765, p. 1224 DOI:
10.1126/science.311.5765.1224) entitled: "As H5N1 Keeps Spreading, a
Call to Release More Data"
"PARIS: An impassioned call by a prominent Italian influenza
scientist has renewed the debate about how to balance global health
against scientists' needs to publish and countries' demands for
secrecy.
On 16 Feb 2006, Ilaria Capua of the Istituto Zooprofilattico
Sperimentale
delle Venezie in Italy asked more than 50 colleagues
around the world to
release all sequence data for the H5N1 avian
influenza strain into the
public domain. Comparing sequence data from
every H5N1 isolate as soon as
they become available is crucial for
understanding how the virus moves and
evolves, Capua argues.
Putting her money where her mouth is, Capua
entered H5N1 sequence
data from 2 recently infected countries, Nigeria and
Italy, into the
GenBank database the same day. She also rejected an offer by
the
World Health Organization (WHO) to join a select circle of 15 labs
that share bird flu sequences on a password-protected Web
site.
Capua's lab is a reference center for the U.N. Food and Agriculture
Organization (FAO) and the World Organisation for Animal Health
(OIE),
and officials at those agencies say they support her call. But
some
scientists say sharing data instantly is complicated by the need
for credit,
and WHO argues that without some form of confidentiality,
some countries
would not submit samples at all.
Sharing information about H5N1 has been
tricky from the start. WHO,
FAO, and OIE encourage countries to send virus
samples to specialized
reference labs that can confirm the outbreak and
study the virus
further. Some have been reluctant to do so because they
worry about
intellectual-property rights or not receiving a fair share of
the
scientific credit; China, for instance, has not shared any avian
samples for a year, a WHO spokesperson says. But even when reference
labs do get their hands on a virus, they don't always release the
data
immediately.
For instance, in the past few months, H5N1 samples from
about 15
European countries have been sent to the Veterinary Laboratories
Agency (VLA) in Weybridge, U.K., a reference lab for OIE and the
European Union. Lab director Ian Brown says he's sharing sequence and
other data with governments and the international agencies; to show
support for Capua's campaign, he also submitted the sequence of a
virus
from an outbreak in Turkey that he says is a "progenitor to the
European
epidemic" into GenBank last week. However, until a paper
about the European
outbreaks -- which he says could be submitted in a
matter of weeks -- has
been accepted, Brown says he needs to hold on
to the European sequences.
"The staff in this institute is working
24/7 to provide this service," he
says. "I don't think it's
unreasonable to expect ... for their endeavors."
It also takes time
to negotiate the conditions of release with dozens of
individual
governments, Brown says.
Capua counters that just
isolating and sequencing a virus that comes
in the mail does not give
researchers the right to sit on the data,
especially not at a government
lab. "Most of us are paid to protect
human and animal health," she says. "If
publishing one more paper
becomes more important, we have our priorities
messed up."
Governments can often be persuaded to release the sequences,
adds
Capua, who repeated her call at an OIE meeting in Paris on Monday [3
Mar 2006?] and also plans to submit it to ProMED, an e-mail list
about
emerging infectious diseases.
WHO agrees that in an ideal world,
scientists would share their data
widely and voluntarily, says Wenqing Zhang
of the agency's Global
Influenza Programme. But because that's not
happening, the agency
created a special secured section at the Influenza
Sequence Database
at Los Alamos National Laboratory in New Mexico in 2004.
Currently,
some 15 labs have passwords to access these data, says Zhang,
including WHO's 8 reference labs. The system is invaluable for WHO,
she
adds, as it helps the agency track the virus and adjust risk
assessments if
necessary.
Virologist Yi Guan of the University of Hong Kong, which has a
huge
H5N1 collection, says he would be prepared to release more data
publicly before publication but is looking for WHO to establish a new
policy. Until then, WHO's secure server at least ensures that
policymakers and most of the scientists who advise them have access
to
vital information. But Capua says everyone with an interest should
be able
to browse all the data. When she was offered access in
exchange for
submitting her Nigerian sequence last month [February
2006], she declined.
And the system gets mixed marks within WHO as
well. "Personally, I'm not in
favor of it," says WHO scientist
Michael Perdue.
Whether scientists'
fears of being scooped are justified is difficult
to say. In theory, once
sequences are posted in the public domain,
anybody could write a paper about
them. In practice, journal editors
will ask manuscript authors to get
permission if they write a paper
about unpublished data they did not submit
to GenBank themselves,
says Caroline Ash, who edits infectious diseases
papers at Science.
But Brown says he'd rather not take that
risk."